Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 23, 2020
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
R A Stahel, A Curioni-Fontecedro, S Rohrmann, et al.
Radiation Oncology (London, England)
|
January 26, 2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
M Pavic, M Niyazi, L Wilke, et al.
The British Journal of Radiology
|
July 8, 2015
Stereotactic body radiotherapy for central lung tumours: Author reply
S Adebahr, S Collette, E Shash, et al.
The British Journal of Radiology
|
April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
S Adebahr, S Collette, E Shash, et al.
EJNMMI Research
|
July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
M Pavic, M Bogowicz, J Kraft, et al.
Radiation Oncology (London, England)
|
April 16, 2022
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
J Ristau, J Hörner-Rieber, C Buchele, et al.
Frontiers in Oncology
|
December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
H S Gabryś, L Basler, S Burgermeister, et al.
ESMO Open
|
July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)
J Seligmann, T Koessler, M Mauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 19, 2024
Response to "Are roots really not worth considering?"
M Guckenberger, R S Guninski, N Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 4, 2023
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
M Guckenberger, N Andratschke, C Belka, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Lung Cancer (Amsterdam, Netherlands)
|
June 23, 2020
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
R A Stahel, A Curioni-Fontecedro, S Rohrmann, et al.
Radiation Oncology (London, England)
|
January 26, 2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
M Pavic, M Niyazi, L Wilke, et al.
The British Journal of Radiology
|
July 8, 2015
Stereotactic body radiotherapy for central lung tumours: Author reply
S Adebahr, S Collette, E Shash, et al.
The British Journal of Radiology
|
April 16, 2015
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
S Adebahr, S Collette, E Shash, et al.
EJNMMI Research
|
July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
M Pavic, M Bogowicz, J Kraft, et al.
Radiation Oncology (London, England)
|
April 16, 2022
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
J Ristau, J Hörner-Rieber, C Buchele, et al.
Frontiers in Oncology
|
December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
H S Gabryś, L Basler, S Burgermeister, et al.
ESMO Open
|
July 24, 2025
Durvalumab and tremelimumab plus local partial tumour ablation (radiofrequency ablation or stereotactic radiotherapy) in patients with unresectable liver metastases from metastatic colorectal cancer: results of the EORTC-1560-GITCG multicentre, single-arm phase II study (ILOC)
J Seligmann, T Koessler, M Mauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 19, 2024
Response to "Are roots really not worth considering?"
M Guckenberger, R S Guninski, N Andratschke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 4, 2023
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
M Guckenberger, N Andratschke, C Belka, et al.
Page
of 7